These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10831340)

  • 21. Utilization of ovarian cancer screening by women at increased risk.
    Schwartz M; Lerman C; Daly M; Audrain J; Masny A; Griffith K
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):269-73. PubMed ID: 7606202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of ovarian tumors by transvaginal Doppler ultrasound with color flow imaging].
    Kawai M; Maeda O; Iwata M; Oguchi H; Kojima M; Kikkawa F; Tomoda Y
    Rinsho Byori; 1992 Feb; 40(2):146-51. PubMed ID: 1583786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian cancer screening in the general population.
    Mathis J; Jellouli MA; Sabiani L; Fest J; Blache G; Mathevet P
    Horm Mol Biol Clin Investig; 2019 Nov; 41(3):. PubMed ID: 31693493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer.
    Fukuyama A; Yokoyama Y; Wada J; Hashimoto T; Oda T; Sato S; Mizunuma H
    Eur J Gynaecol Oncol; 2009; 30(2):208-10. PubMed ID: 19480258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography--study on size of ovary to select subjects requiring second screening].
    Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1173-9. PubMed ID: 1453046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is ultrasound screening for ovarian cancer possible in 1998?].
    Descamps P; Fondrinier E; Biquard F; Binelli C; Lepinard C; Loisel D; Crvencowitcz G; Platt LD; Karlan BY
    J Gynecol Obstet Biol Reprod (Paris); 1998 Sep; 27(5):476-81. PubMed ID: 9791573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy.
    Sassone AM; Timor-Tritsch IE; Artner A; Westhoff C; Warren WB
    Obstet Gynecol; 1991 Jul; 78(1):70-6. PubMed ID: 2047071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Features of ultrasound diagnosis of non-epithelial ovarian carcinoma].
    Meshkova IE; Volkova AV; Semenov II
    Vopr Onkol; 2007; 53(3):345-51. PubMed ID: 18198619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuing participation supports ultrasound screening for ovarian cancer.
    Pavlik EJ; Johnson TL; Depriest PD; Andrykowski MA; Kryscio RJ; Van Nagell JR
    Ultrasound Obstet Gynecol; 2000 May; 15(5):354-64. PubMed ID: 10976474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transvaginal ultrasonography in nonpregnant and postmenopausal women.
    Weissman AM; Barloon TJ
    Am Fam Physician; 1996 May; 53(6):2065-72. PubMed ID: 8623719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic challenges in patients with tumors: case 3. Normal-sized ovarian cancer detected by color doppler ultrasound using a microbubble contrast agent.
    Emoto M; Fujimitsu R; Iwasaki H; Kawarabayashi T
    J Clin Oncol; 2003 Oct; 21(19):3703-5. PubMed ID: 14512405
    [No Abstract]   [Full Text] [Related]  

  • 32. Ovarian cancer screening: a look at the evidence.
    Fields MM; Chevlen E
    Clin J Oncol Nurs; 2006 Feb; 10(1):77-81. PubMed ID: 16482731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mass-screening for ovarian cancer by transvaginal ultrasonography--study on tumor markers at the second screening].
    Sato S; Sugo T; Maruyama H; Saito Y; Hasuo Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1247-53. PubMed ID: 7844443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian cancer screening in asymptomatic postmenopausal women.
    DePriest PD; van Nagell JR; Gallion HH; Shenson D; Hunter JE; Andrews SJ; Powell DE; Pavlik EJ
    Gynecol Oncol; 1993 Nov; 51(2):205-9. PubMed ID: 8276295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility in the assessment of postmenopausal ovaries with transvaginal ultrasound.
    Modugno F; Weissfeld JL; Hill LM
    Gynecol Oncol; 2000 May; 77(2):289-92. PubMed ID: 10785480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic potential of ultrasound examination for tumor recurrence and metastasis].
    Meshkova IE; Kostromina EV; Trouk EB
    Vopr Onkol; 2000; 46(1):84-7. PubMed ID: 10789232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transvaginal ultrasound and computed tomography combined with clinical parameters and CA-125 determinations in the differential diagnosis of persistent ovarian cysts in premenopausal women.
    Guerriero S; Mallarini G; Ajossa S; Risalvato A; Satta R; Mais V; Angiolucci M; Melis GB
    Ultrasound Obstet Gynecol; 1997 May; 9(5):339-43. PubMed ID: 9201878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian cancer screening.
    Kurjak A; Predanic M
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preconceptions versus experience of transvaginal ultrasonography in older women.
    Kew FM; Whittaker VJ; Cruickshank DJ
    Ultrasound Obstet Gynecol; 2004 Oct; 24(5):572-4. PubMed ID: 15386605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer.
    Bourne TH; Campbell S; Reynolds K; Hampson J; Bhatt L; Crayford TJ; Whitehead MI; Collins WP
    Gynecol Oncol; 1994 Mar; 52(3):379-85. PubMed ID: 8157195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.